Validation of the HeartQol questionnaire in patients with non-valvular atrial fibrillation and flutter

Main Article Content

O. S. Sychov
A. O. Borodai
E. S. Borodai

Abstract

The aim – to evaluate the psychometric properties of HeartQoL in patients with non-valvular atrial fibrillation-flutter (AF–AFl), by assessing its internal consistency, construct validity, and test-retest reliability.
Material and methods. The study consisted of two phases: cross sectional, including 329 patients with AF–AFl who filled in HeartQol, SF-12, AFEQT and HADS for the evaluation of internal consistency, construct, discriminative validities and longitudinal one, including 53 patients completing HeartQoL twice to evaluate test-retest reliability.
Results. Internal consistency was sufficient, Cronbach’s alpha (α)=0.94 for physical HeartQol scale and 0.88 for psychological HeartQol scale. The construct validity was sufficient, as subscales of HeartQoL had moderate to strong correlations with similar (r≥0.55) and weakly correlated (r≤0.55) with dissimilar subscales of other questionnairies. The HeartQoL demonstrated ability to distinguish between different clinical subgroups of patients, indicating sensitivity.
Conclusions. The HeartQoL showed overall satisfactory psychometric properties, demonstrating it to be a valid instrument in the evaluation of health related quality of life in patients with AF–AFl.

Article Details

Keywords:

atrial fibrillation – flutter, health related quality of life, HeartQol

References

Сычев О.С., Бородай А.А., Федькив С.В., Бородай Э.С. Качество жизни, тревога, депрессия и когнитивная дисфункция у больных с фибрилляцией предсердий неклапанного происхождения и немыми инфарктами головного мозга // Укр. кардіол. журнал.– 2015.– № 1.– С. 54–65.

Aliot E., Botto G.L., Crijns H.J., Kirchhof P. Quality of life in patients with atrial fibrillation: how to assess it and how to improve it // Europace.– 2014.– Vol. 16 (6).– P. 787–796.

Bjelland I., Dahl A.A., Haug T.T., Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review // J. Psychosom. Res.– 2002.– Vol. 52 (2).– P. 69–77.

Brooks R., Rabin R., de Charro F. The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective – Evidence from the EuroQol BIOMED Research Program.– The Netherlands: Kluwer; 2003.– 299 p.

Carlson K.D., Herdman A.O. Understanding the impact of convergent validity on research results // Organizational. Research Methods.– 2012.– Vol. 15.– P. 17–32.

Kristensen M.S., Zwister A.D., Berg S.K. et al. Validating the HeartQol questionnaire in patients with atrial fibrillation // Eur. J. Prev. Cardiol.– 2016.– Vol. 23 (14).– P. 1496–1503. doi: 10.1177/2047487316638.

Lang R.M., Badano L.P., Mor-Avi V. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging // J. Am. Soc. Echocardiogr.– 2015.– Vol. 28 (1).– P. 1–39.

Nagueh S., Appleton C., Gillebert T. et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography // J. Amer. Soc. Echocardiogr.– 2009.– Vol. 22 (2).– P. 107–133.

Oldridge N., Höfer S., McGee H. et al. HeartQoL: part II. Validation of a new core health-related quality of life questionnaire for patients with ischemic heart disease // Eur. J. Prev. Cardiol.– 2014.– Vol. 21 (1).– P. 98–106.

Shapiro P. Heart disease // American Psychiatric Publishing Textbook of Psychosomatic Medicine / Ed. J.L. Levenson.– American Psychiatric Publishing: Washington, 2005.– P. 423–444.

Spertus J., Dorian P., Bubien R. et al. Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation // Circ. Arrhythm. Electrophysiol.– 2011.– Vol. 4 (1).– P. 15–25.

Ware J., Kosinski M., Keller S.D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity // Med. Care.– 1996.– Vol. 34 (3).– P. 220–233.